Member Info for BigDave13

190m new shares?

FIN interims tomorrow, expecting positive results

https://www.lse.co.uk/rns/FIN/notice-of-interim-results-presentation-mimp6g09xp8yldf.html

Vela will continue to trade as long as it has liquid investments it can sell to pay the Directors Fees. This will carry on for years.

An independent Director is appointed immediately who has authority to hire/fire Directors for failing to meet pre agreed metrics.

Each Director buys 10% of the company to show their commitment to the cause.

No more investments on AQSE and to liquidate those currently on that exchange.

Directors reduce their fees by 50% for a minimum of 12 months to conserve cash

etc

Yes JB, the presentation is much better.

ENET is AIM, not AQSE

Hopefully Dr T meets some friendly investors willing to punt some money into CDT.

https://finance.yahoo.com/news/conduit-pharmaceuticals-present-h-c-120000789.html

*

Interims due in a couple of weeks so I expect continued strength leading into it as last trading update was positive.

Per recent investment updates, Vela announced 195k shares sold

Do you think the SP will go higher from here or has maxed out since they barely make a profit? MWE H1 interims appear to be much stronger yet SKL has a marginally higher MC. Maybe MWE is way undervalued but their SP has been stagnant for a couple of years.

Latest prospectus issued includes this comment - We currently anticipate that cash required for working capital for the next 12 months is approximately $17.1 million

Grabbed a few in the $16s.

Interesting times!

Good find, that does seem to tie into the 2 tranches the report refers to. US about to open ,let's see how the market reacts.

Those 100% turnover days were weird given the high level of insider holdings so more like 5x - 10x of the supposed free float. Now we know why this unusual trading activity occurred but I have no idea what the implications are here and whether this will be good or bad for the company/SP. Maybe an opportunity once this unwinds and there is some clarity and transparency on current shareholders?

Vela were eager to release an announcement on the recent Astra licence. I expect a RNS 7.00am Mon to update the market on this 'cluster' and outline the immediate impact on Vela and their intended actions to address this issue.

https://www.investegate.co.uk/announcement/rns/vela-technologies--vela/update-re-investment-in-conduit-pharmaceuticals-/8359731

* Volvie may want to cancel that beach holiday for now :-)

I would use an alternative approach.

Vela shares 71,429 / CSIL Shares in Issue 10,456,021 * CSIL owned WeShop shares 8,333,333 = 56,926 (assuming full distribution and no further dilution) * Weshop own value £6.19 https://we.shop/corporate/ = £352k

Lots of variables, probably true value somewhere between our numbers.

There is a $5m commitment letter from Corvus Capital available which will help short term but agree more funding required with potential further dilution. Pre Mkt showing the usual spike.

0.1375

-0.0325

(-19.12%)

At close: 4:00 PM EDT

Might be time for another buy soon!

Https://finance.yahoo.com/news/conduit-pharmaceuticals-selects-initial-indications-110000664.html

Success being commercialisation post phase II trials for one of the indications they have licenced? Not expecting any news on that front for quite some time, years even.

Vela holds 1,005,760 common shares in Conduit representing 0.46% of Conduit's issued share capital.

There are ~74m shares outstanding (pre any recent share issues to funder and AZD) so Vela holding cannot equate to 0.46%. All things being equal, holding would be more like 1.35%. What am I missing here?

Yep, also sold for a small profit. Punters now realising dilution and lack of funding may be an issue and selling off.